Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inosine-5'-monophosphate dehydrogenase 1 (IMPDH1) is an enzyme that catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the rate-limiting step in guanine nucleotide biosynthesis. This enzyme is crucial for regulating cell growth and is a target for immunosuppressive drugs. Mutations in IMPDH1 are associated with retinitis pigmentosa type 10.
Inhibition of IMPDH1, leading to depletion of guanine nucleotides
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inosine-5'-monophosphate dehydrogenase 1 (None).